Search results
Results from the Tech24 Deals Content Network
List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...
Meril Life Sciences is an Indian multinational medical device company, with headquarters in Vapi, Gujarat, India. It was founded in 2006 and is a part of the Bilakhia Group. [2] The company is engaged in the manufacturing of vascular intervention devices, orthopedic implants, endosurgery, ENT products and in-vitro diagnostics. Meril Life ...
Johnson & Johnson. / 40.49861°N 74.44361°W / 40.49861; -74.44361. Johnson & Johnson ( J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones ...
The company had previously planned to be 80% electric by 2030; but just last month Porsche tapped the brakes and told Reuters that goal is now “dependent on customer demand.”
ArborXR, a startup that helps companies remotely manage AR and VR devices, believed that enterprise customers would be the primary targets for AR and VR devices.Now, that bet is paying off. On ...
In medical technologies, J&J's major franchises include interventional solutions, orthopedics, surgery, and vision. [1] Heart and Cardiac. Abiomed. Ear, nose and throat ( Acclarent) (2010–2024) Eustachian Tube Balloon Dilation System [2] Navigation Balloon Dilation System [3]
14. Penumbra, Inc. (NYSE:PEN) Market Cap as of November 18: $7.34 B . Number of Hedge Fund Holders: 27. Penumbra, Inc. (NYSE:PEN) is a medical device company that manufactures products for the ...
Pharmaceutical industry in India. The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. [ 1] India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the ...